Psoriasis and COVID-19: A bidirectional Mendelian randomization study - 16/03/23
Funding sources: This study was funded by the Operational Program “Competitiveness, Entrepreneurship, & Innovation” (OΠΣ 5047228) & “Flagship Action” for the study of SARS-CoV-2 infection: Epidemiological study in Greece via extensive testing for viral and antibody detection, sequencing of the virome, and genetic analysis of the carriers (GSRT No. 2020ΣΕ01300001). |
|
IRB approval status: Not applicable. |
|
Patient consent: Not applicable. |
|
Key words: COVID-19; dermatology; epidemiology; genetics; Mendelian randomization; psoriasis. |
Vol 88 - N° 4
P. 893-895 - avril 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.